References
- Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 1982; 79: 5485–5489
- Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296: 659–660
- Sundler F, Moghimzadeh E, Håkanson R, Ekelund M, Emson P. Nerve fibres in the gut and pancreas of the rat displaying neuropeptide Y immuno-reactivity. Cell Tissue Res 1983; 230: 487–493
- Koch T R, Roddy D R, Carney J A, Telander R L, Go V LW. Distribution, quantitation and origin of immunoreactive neuropeptide Y in the human gastrointestinal tract. Reg Peptides 1988; 21: 309–319
- Lundberg J M, Terenius L, Hökfelt T, Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 1983; 42: 167–172
- Ekblad E, Håkanson R, Sundler F. VIP and PHI coexist with an NPY-like peptide in intramural neurons of the small intestine. Reg Peptides 1984; 10: 47–55
- Furness J B, Costa M, Keast J HR. Choline acetyl-transferase and peptide immunoreactivity of sub-mucous neurons in the small intestine of the guinea pig. Cell Tissue Res 1984; 237: 329–336
- Hellström P M, Olerup Ö, Tatemoto K. Neuropeptide Y may mediate effects of sympathetic nerve stimulations on colonic motility and blood flow in the cat. Acta Physiol Scand 1985; 124: 613–624
- Saria A, Beubler E. Neuropeptide Y (NPY) and peptide YY (PYY) inhibit prostaglandin E2-induced intestinal fluid and electrolyte secretion in the rat ieiunum in vivo. Eur J Pharmacol 1985; 119: 47–52
- Read A E, Gough K R, Bones J A, McCarthy CF. An improvement to the Crosby peroral intestinal biopsy capsule. Lancet 1962; 1: 894–895
- Alexander JO. Dermatitis herpetiformis. Major Probl Dermatol 1975; 4: 236
- Van Noorden S. Tissue preparations and immuno-staining techniques for light microscopy. Immunocytochemistry. Modern methods and applications.2nd ed., J M Polak, S van Noorden. Wright, Bristol 1986; 26–53
- Bishop A E, Polak J M, Bloom SR. Pathology of gut peptidergic innervation. Gut hormones.2nd ed., S R Bloom, J M Polak. Churchill Livingstone, Edinburgh 1981; Vol. 2.: 569–575
- Böttcher G, Sjölund K, Ekblad E, Håkanson R, Schwartz T W, Sundler F. Coexistence of peptide YY and glicentin in endocrine cells of the gut. Reg Peptides 1984; 8: 261–266
- Challacombe D N, Robertson K. Enterochromaffin cells in the duodenal mucosa of children with coeliac disease. Gut 1977; 18: 373–376
- Polak J M, Bloom S R, McCrossan M V, et al. Chole-cystokinin abnormalities in coeliac disease [Abstract]. Gastroenterology 1978; 74: 1078
- Sjölund K, Aluments J, Berg N O, Håkanson R, Sundler F. Duodenal endocrine cells in adult coeliac disease. Gut 1979; 20: 547–552
- Sjöund K, Aluments J, Berg N O, Håkanson R, Sundler F. Enteropathy of coeliac disease in adults; increased number of enterochromaffin cells in the duodenal mucosa. Gut 1982; 23: 42–48
- Challacombe D N, Dawkins P D, Baker P. Increased tissue concentrations of 5-hydroxytryptamine in the duodenal mucosa of children with coeliac disease. Gut 1977; 18: 882–886
- Sjölund K, Håkanson R, Lundquist G, Sundler F. Duodenal somatostatin in coeliac disease. Scand J Gastroenterol 1982; 17: 969–976
- Calam J, Ellis A, Dockray G. Identification and measurement of molecular variants of cholecys-tokinin in duodenal mucosa and plasma; diminished concentrations in patients with coeliac disease. J Clin Invest 1982; 69: 218–225
- Bishop A E, Polak J M, Bryant M G, Bloom S RI, Hamilton S. Abnormalities of vasoactive intestinal polypeptide containing nerves in Crohn's disease. Gastroenterology 1980; 79: 853–860
- Sjölund K, Schaffalitzky de Muckadell O B, Fah-Renkrug J, Håkanson R, Peterson B G, Sundler F. Peptide containing nerve fibres in gut wall in Crohn's disease. Gut 1983; 24: 724–733
- Aggestrup S, Emson P, Uddman R, Sundler F, Jensen S L, Sörensen HR. Distribution and content of neuropeptide Y in the human lower oesophageal sphincter. Digestion 1987; 36: 68–73